A 72-year-old male of Caucasian descent was referred for consideration of systemic therapy after receiving a diagnosis of hepatocellular carcinoma (HCC). His past medical history was unremarkable with no comorbidities and he was not on any other medications.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.
